Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID‐19: a rapid review and meta‐analysis
This study aimed to examine the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for
coronavirus disease 2019 (COVID‐19). PubMed, Cochrane Library, Web of Science …
coronavirus disease 2019 (COVID‐19). PubMed, Cochrane Library, Web of Science …
Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID-19: A rapid review and meta-analysis
B Amani, B Amani - Journal of medical virology, 2023 - pubmed.ncbi.nlm.nih.gov
This study aimed to examine the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for
coronavirus disease 2019 (COVID-19). PubMed, Cochrane Library, Web of Science …
coronavirus disease 2019 (COVID-19). PubMed, Cochrane Library, Web of Science …
[HTML][HTML] Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID‐19: A rapid review and meta‐analysis
B Amani, B Amani - Journal of Medical Virology, 2023 - ncbi.nlm.nih.gov
This study aimed to examine the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for
coronavirus disease 2019 (COVID‐19). PubMed, Cochrane Library, Web of Science …
coronavirus disease 2019 (COVID‐19). PubMed, Cochrane Library, Web of Science …
Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID-19: a rapid review and meta-analysis.
B Amani - Journal of Medical Virology, 2022 - europepmc.org
This study aimed to examine the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for
coronavirus disease 2019 (COVID‐19). PubMed, Cochrane Library, Web of Science …
coronavirus disease 2019 (COVID‐19). PubMed, Cochrane Library, Web of Science …
Efficacy and safety of nirmatrelvir/ritonavir (paxlovid) for COVID-19: a rapid review and meta-analysis.
B Amani, B Amani - 2022 - cabidigitallibrary.org
This study aimed to examine the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for
coronavirus disease 2019 (COVID-19). PubMed, Cochrane Library, Web of Science …
coronavirus disease 2019 (COVID-19). PubMed, Cochrane Library, Web of Science …
Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID-19: A rapid review and meta-analysis
B Amani - Journal of Medical Virology, 2023 - eprints.medilam.ac.ir
This study aimed to examine the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for
coronavirus disease 2019 (COVID-19). PubMed, Cochrane Library, Web of Science …
coronavirus disease 2019 (COVID-19). PubMed, Cochrane Library, Web of Science …
Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID‐19: A rapid review and meta‐analysis.
B Amani, B Amani - Journal of Medical Virology, 2023 - search.ebscohost.com
This study aimed to examine the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for
coronavirus disease 2019 (COVID‐19). PubMed, Cochrane Library, Web of Science …
coronavirus disease 2019 (COVID‐19). PubMed, Cochrane Library, Web of Science …
Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID-19: a rapid review and meta-analysis.
B Amani - Journal of Medical Virology, 2022 - europepmc.org
This study aimed to examine the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for
COVID-19. PubMed, Cochrane Library, Web of Science, medRxiv, and Google Scholar were …
COVID-19. PubMed, Cochrane Library, Web of Science, medRxiv, and Google Scholar were …
Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID-19: A rapid review and meta-analysis
B Amani - Journal of Medical Virology, 2023 - eprints.medilam.ac.ir
This study aimed to examine the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for
coronavirus disease 2019 (COVID-19). PubMed, Cochrane Library, Web of Science …
coronavirus disease 2019 (COVID-19). PubMed, Cochrane Library, Web of Science …